$11.48 0.2%
NEOG Stock Price vs. AI Score
Data gathered: January 31

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Neogen (NEOG)

Analysis generated January 9, 2025. Powered by Chat GPT.

Neogen Corporation specializes in the development and marketing of products dedicated to food and animal safety. The company’s offerings are bifurcated into two primary categories: Food Safety and Animal Safety. Neogen's Food Safety division provides diagnostic test kits and other products to detect foodborne pathogens, natural toxins, genetic modifications, food allergens, drug and chemical residues, pesticides, ruminant byproducts, and other contaminants. Meanwhile, the Animal Safety division offers a broad range of veterinary instruments, pharmaceuticals, vaccines, topicals, and diagnostic products to the worldwide animal safety market.

Read full AI stock Analysis

Stock Alerts - Neogen (NEOG)

company logo Neogen | January 23
Price is down by -5.1% in the last 24h.
company logo Neogen | January 17
Insider Alert: Naemura David H. is buying shares
company logo Neogen | January 15
Price is down by -5.3% in the last 24h.
company logo Neogen | January 14
Price is down by -5% in the last 24h.

About Neogen

Neogen Corporation, together with its subsidiaries, develops, manufactures, and markets various products for food and animal safety worldwide.


Neogen
Price $11.48
Target Price Sign up
Volume 2,350,000
Market Cap $2.49B
Year Range $11.36 - $17.71
Dividend Yield 0%
PE Ratio 865
Analyst Rating 50% buy
Industry Medical & Dental Instruments

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q4 '24463M693M113M-456M-457M0.110
Q3 '24434M210M105M-13M33M0.070
Q1 '24447M236M117M-2M28M0.120
Q4 '23449M233M117M-3.5M30M0.110
Q3 '23450M227M117M1.5M36M0.110

Insider Transactions View All

ADENT JOHN EDWARD filed to buy 269,164 shares at $11.
January 16 '25
Naemura David H. filed to buy 61,434 shares at $11.1.
January 16 '25
ADENT JOHN EDWARD filed to buy 216,477 shares at $13.8.
October 15 '24
Tobin James P filed to buy 23,392 shares at $16.9.
August 7 '24
Jones Douglas Edward filed to buy 46,131 shares at $12.4.
April 17 '24

What is the Market Cap of Neogen?

The Market Cap of Neogen is $2.49B.

What is Neogen's PE Ratio?

As of today, Neogen's PE (Price to Earnings) ratio is 865.

What is the current stock price of Neogen?

Currently, the price of one share of Neogen stock is $11.48.

How can I analyze the NEOG stock price chart for investment decisions?

The NEOG stock price chart above provides a comprehensive visual representation of Neogen's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Neogen shares. Our platform offers an up-to-date NEOG stock price chart, along with technical data analysis and alternative data insights.

Does NEOG offer dividends to its shareholders?

As of our latest update, Neogen (NEOG) does not offer dividends to its shareholders. Investors interested in Neogen should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Neogen?

Some of the similar stocks of Neogen are Align Technology, Dentsply, LeMaitre Vascular, iRhythm Technologies, and NovoCure.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2025 AltIndex. All rights reserved.